166 related articles for article (PubMed ID: 5338225)
1. [Ambulatory endoxan therapy by high doses].
Fischer M; Martin H; Schubert JC
Dtsch Med Wochenschr; 1967 Jun; 92(25):1145-50. PubMed ID: 5338225
[No Abstract] [Full Text] [Related]
2. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
Danieli G
G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
[No Abstract] [Full Text] [Related]
3. Chemotherapy of the lymphomas.
Lacher MJ
Med Times; 1970 May; 98(5):96-102. PubMed ID: 4911076
[No Abstract] [Full Text] [Related]
4. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Cajozzo A; Citarrella P; Carreca I; D'Eredità F
Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
[No Abstract] [Full Text] [Related]
5. [New viewpoints for indication for radiologic treatment in leukoses and retikuloses].
Musshoff K
Strahlentherapie; 1968 Jun; 135(6):641-55. PubMed ID: 4878792
[No Abstract] [Full Text] [Related]
6. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
7. [Use of milurit in hyperuricemia in patients with malignant hemopathies].
Poddubnaia IV; Mansurov AN; Fominykh VG
Klin Med (Mosk); 1975 Mar; 53(3):94-9. PubMed ID: 1090781
[No Abstract] [Full Text] [Related]
8. [Methylhydrazine in the therapy of malignant lymphopathies].
Beltrametti L; Almici C
Policlinico Prat; 1967 Jan; 74(3):82-5. PubMed ID: 4878309
[No Abstract] [Full Text] [Related]
9. Combined radiotherapy and chemotherapy of lymphomas and other cancers.
Stutzman L
Cancer Res; 1971 Nov; 31(11):1845-50. PubMed ID: 4941353
[No Abstract] [Full Text] [Related]
10. [Results of cytostatic therapy of malignant hemoblastoses].
Stacher A
Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
[No Abstract] [Full Text] [Related]
11. [Ixoten therapy in malignant lymphomas].
Pötzi P; Aiginger P; Kühböck J
Acta Med Austriaca; 1979; 6(5):247-9. PubMed ID: 400215
[TBL] [Abstract][Full Text] [Related]
12. Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.
Cridland MD
Drugs; 1972; 3(5):331-51. PubMed ID: 4347084
[No Abstract] [Full Text] [Related]
13. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
Hansen MM; Hertz H; Videaek A
Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
[No Abstract] [Full Text] [Related]
14. [Combined chemotherapy with asaline and cyclophosphane under experimental and clinical conditions].
Vershinina SF; Gershanovich ML; Chekharina EA
Vopr Onkol; 1969; 15(11):48-53. PubMed ID: 4904839
[No Abstract] [Full Text] [Related]
15. [High-dosed cyclophosphamide therapy of malignant diseases of the lymphoreticulum].
Kühböck J; Pietschmann H
Wien Klin Wochenschr; 1965 Nov; 77(44):883-6. PubMed ID: 5328863
[No Abstract] [Full Text] [Related]
16. [Different response of superficial and deep lymph nodes to drug therapy in malignant lymphoreticulopathy].
Morgenfeld MC; Helft F; Bomchil G
Therapeutique; 1969 Mar; 45(3):294-300. PubMed ID: 4989245
[No Abstract] [Full Text] [Related]
17. How to use cancer chemotherapy.
Dollinger MR
Am Fam Physician; 1971 Jun; 3(6):73-84. PubMed ID: 4325596
[No Abstract] [Full Text] [Related]
18. Present management of the lymphomas.
Kabakow B
Proc Rudolf Virchow Med Soc City N Y; 1970-1971; 28():39-45. PubMed ID: 4950557
[No Abstract] [Full Text] [Related]
19. Recent advances in chemotherapy of lymphoma.
Lenhard RE; Owens AH
Johns Hopkins Med J; 1967 Aug; 121(2):136-40. PubMed ID: 5340335
[No Abstract] [Full Text] [Related]
20. The effects of two alkaloids derived from Vinca rosea on the malignant cells of Hodgkin's disease, lymphosarcoma and acute leukemia in vivo.
Marmont AM; Damasio EE
Blood; 1967 Jan; 29(1):1-21. PubMed ID: 5334796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
